Timothy R Rebbeck Selected Research

Timothy R Rebbeck Research Topics

Disease

71	Neoplasms (Cancer) 08/2022 - 01/2002
44	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2002
39	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2002
14	Ovarian Neoplasms (Ovarian Cancer) 08/2020 - 05/2002
11	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 09/2006
8	Carcinogenesis 01/2021 - 01/2002
6	Carcinoma (Carcinomatosis) 12/2021 - 05/2002
5	Inflammation (Inflammations) 01/2022 - 09/2008
5	Obesity 01/2021 - 02/2011
5	Melanoma (Melanoma, Malignant) 06/2015 - 03/2002
3	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2002
2	COVID-19 01/2022 - 08/2021
2	Body Weight (Weight, Body) 10/2020 - 02/2011
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2017 - 02/2007
2	Disease Progression 09/2015 - 04/2015
2	Hot Flashes 06/2012 - 09/2010
2	Genetic Predisposition to Disease (Genetic Predisposition) 09/2011 - 09/2004
1	Monoclonal Gammopathy of Undetermined Significance 05/2022
1	Hematologic Neoplasms (Hematological Malignancy) 05/2022
1	Paraproteinemias (Monoclonal Gammopathy) 05/2022
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Multiple Myeloma 01/2022
1	Margins of Excision 07/2021
1	Adenocarcinoma 07/2021
1	Circulating Neoplastic Cells 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2002
9	Hormones (Hormone)IBA 01/2015 - 01/2002
9	Estrogen ReceptorsIBA 12/2014 - 01/2005
9	Estrogens (Estrogen)FDA Link 07/2013 - 01/2005
8	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 02/2002
8	Cytochrome P-450 CYP3AIBA 04/2013 - 11/2004
7	Proteins (Proteins, Gene)FDA Link 08/2022 - 04/2011
7	Biological ProductsIBA 01/2022 - 01/2010
7	AndrogensIBA 01/2020 - 09/2008
6	Prostate-Specific Antigen (Semenogelase)IBA 07/2021 - 02/2008
6	ORALIT (ORS)IBA 01/2021 - 03/2006
6	Genetic Markers (Genetic Marker)IBA 01/2017 - 10/2002
5	EnzymesIBA 08/2014 - 08/2005
4	SteroidsIBA 06/2012 - 03/2006
3	NucleotidesIBA 06/2022 - 04/2015
3	GenieIBA 06/2022 - 01/2020
3	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 06/2011
3	Sulfates (Sulfates, Inorganic)IBA 01/2015 - 01/2005
3	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 06/2012 - 03/2007
3	Pharmaceutical PreparationsIBA 05/2012 - 08/2005
3	Progesterone Receptors (Progesterone Receptor)IBA 10/2011 - 02/2009
2	CytokinesIBA 12/2021 - 01/2021
2	NF-kappa B (NF-kB)IBA 12/2021 - 01/2021
2	Biological FactorsIBA 12/2021 - 09/2015
2	Complement System Proteins (Complement)IBA 05/2021 - 03/2006
2	CholesterolIBA 01/2021 - 01/2021
2	CarcinogensIBA 10/2020 - 01/2002
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2017
2	3' Untranslated Regions (3' UTR)IBA 01/2016 - 03/2011
2	Type 1 Melanocortin ReceptorIBA 06/2015 - 09/2006
2	Aurora Kinase AIBA 01/2015 - 07/2007
2	Oral ContraceptivesIBA 06/2014 - 07/2013
2	Insulin-Like PeptidesIBA 08/2012 - 01/2009
2	Environmental CarcinogensIBA 09/2011 - 09/2004
2	Tamoxifen FDA LinkGeneric 01/2010 - 09/2008
2	Catechol EstrogensIBA 01/2009 - 03/2007
2	Glutathione (Reduced Glutathione)IBA 04/2007 - 09/2004
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 03/2007 - 09/2006
1	RNA (Ribonucleic Acid)IBA 08/2022
1	Blood Proteins (Serum Proteins)IBA 05/2022
1	methylglyoxal bis(butylamidinohydrazone)IBA 05/2022
1	TabletsIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Racemases and Epimerases (Epimerases and Racemases)IBA 12/2021
1	InterleukinsIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Hematoxylin (Haematoxylon)IBA 07/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	A 17 (A-17)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	LipidsIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021

Therapy/Procedure

12	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 09/2010
12	Salpingo-oophorectomy 08/2020 - 03/2006
9	Therapeutics 08/2022 - 09/2002
6	Ovariectomy (Oophorectomy) 12/2007 - 05/2002
5	Drug Therapy (Chemotherapy) 10/2020 - 08/2005
5	Hormone Replacement Therapy (Therapy, Hormone Replacement) 02/2009 - 11/2005
3	Radiotherapy 01/2022 - 06/2006
3	Treatment Delay 01/2022 - 01/2019
3	Adjuvant Chemotherapy 10/2020 - 08/2005
3	Chemoprevention 01/2017 - 01/2002
3	Prophylactic Mastectomy 12/2007 - 05/2002
2	Castration 01/2021 - 07/2019
2	Aftercare (After-Treatment) 01/2020 - 06/2012
2	Mastectomy (Mammectomy) 11/2014 - 09/2010
2	Estrogen Replacement Therapy 10/2006 - 09/2006
1	Continuity of Patient Care 06/2022
1	Lasers (Laser) 05/2022
1	Palliative Care (Palliative Therapy) 01/2022